RAC's review of gene therapy: it's time to move on.
作者信息
Post L E
出版信息
Hum Gene Ther. 1994 Nov;5(11):1311-2; discussion 1313-4. doi: 10.1089/hum.1994.5.11-1311.
PMID:7893802
Abstract
摘要
相似文献
1
RAC's review of gene therapy: it's time to move on.英国皇家化学学会对基因治疗的综述：是时候向前迈进了。
Hum Gene Ther. 1994 Nov;5(11):1311-2; discussion 1313-4. doi: 10.1089/hum.1994.5.11-1311.
2
Big changes at the RAC!皇家汽车俱乐部发生重大变革！
Hum Gene Ther. 1994 Nov;5(11):1309-10. doi: 10.1089/hum.1994.5.11-1309.
3
Recombinant DNA research: actions under the guidelines; notice.重组DNA研究：准则下的行动；通知。
Fed Regist. 1995 Apr 27;60(81):20726-37.
4
NIH guidelines for research involving recombinant DNA molecules.美国国立卫生研究院关于涉及重组DNA分子研究的指南。
Account Res. 1993;3(2-3):177-85. doi: 10.1080/08989629308573848.
5
Public oversight is necessary if human gene therapy is to progress.如果人类基因治疗要取得进展，公众监督是必要的。
Hum Gene Ther. 1996 May 1;7(7):795-7. doi: 10.1089/hum.1996.7.7-795.
6
Recombinant DNA research: proposed actions under the guidelines; notice.重组DNA研究：指南下的拟议行动；通知
Fed Regist. 1997 Feb 14;62(31):7108-23.
7
Molecular medicine. One less hoop for gene therapy.分子医学。基因治疗少了一个障碍。
Science. 1994 Jul 29;265(5172):599. doi: 10.1126/science.8036507.
8
Regulation of human gene therapy.人类基因治疗的监管
Science. 1995 Jul 7;269(5220):14-5. doi: 10.1126/science.7604272.
9
Recombinant DNA research: proposed actions under the guidelines; notice.重组DNA研究：指南下的拟议行动；通知
Fed Regist. 1996 Nov 22;61(227):59726-42.
10
Overregulation is an unnecessary hindrance to human gene therapy.过度调控是人类基因治疗的不必要障碍。
Hum Gene Ther. 1995 Nov;6(11):1361-2. doi: 10.1089/hum.1995.6.11-1361.
Zotero 插件